90 Followers SGX:5G3 - TalkMed (SGD 0.505) TALKMED GROUP LIMITED
Sector: Health Services, Industry: Hospital/Nursing Management

Add to WatchList


SGD 0.505    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

20 Jan 2020


Overview

20 Jan 2020

52 Wk Range: 0.47 - 0.59

Day's Range: 0.505 - 0.505

Last Volume: 12,900

Current Yield: 4.09%

Projected Yield: 4.09%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

20 Jan 2020

Metric 5G3 S.Median
Beta 0.18 0.32
VaR 29.85 26.37
E.Shortfall 86.41 33.34
Liquidity 3,643.08 30.36K

Fundamental

20 Jan 2020

PE: 19.65

Market Cap: 663.8M

Price Over Book: 9.281

Price Over Sales: 9.12

Return On Assets: 39.7%

Return On Equity: 49.8%

NAV Over Price: [Friends Only]

General

CEO: Peng Tiam Ang, MD

Founded Year: 2013

Headquarters: Singapore

Shares Outstanding: 1.3B

Security Type: Stock

Useful Links
Homepage
Investor Relations

Description

Talkmed Group Ltd. is an investment holding company, which engages in the provision of medical oncology, stem cell transplants, and palliative care services. It operates through Oncology Services, and Stem Cells Related Products and Services segments. The Oncology Services segment offers services to Parkway Cancer Centre. The Stem Cells Related Products and Services segment includes processing, culturing, and storage of stem cells to Parkway Cancer Centre. The company was founded on September 10, 2013 and is headquartered in Singapore.